Pytsky V I, Filatov O Y
Department of General Pathology, Medicobiological Faculty, Russian Medical University, Moscow, Russian Federation.
J Investig Allergol Clin Immunol. 1996 Jul-Aug;6(4):256-60.
The purpose of our investigation was to establish how the intensity of induced luminol-dependent chemiluminescence of polymorphonuclear leukocytes is affected by the cultivation of allergen with the blood of allergic patients (pollinosis, bronchial asthma and penicillin allergy) and animals with allergic processes (Arthus' phenomenon, guinea pigs sensitized by horse serum). The results of all assays were uniform. In all cases three phases of changes in induced chemiluminescence were established. In the first phase with the minimum doses of specific and unspecific allergens, either no changes in chemiluminescence were found or chemiluminescence even increased. With higher doses of allergen came the second phase - inhibition of stimulated chemiluminescence when specific allergen had been added and the absence of changes in the tests with unspecific allergen. We defined this phase as the phase of specific chemiluminescence inhibition. With a further increase in the concentration of allergen came the third phase. It expressed itself in the inhibition of stimulated chemiluminescence under the influence of both specific and unspecific allergen. We viewed this phase as a manifestation of the toxic influence of allergen on polymorphonuclear leukocytes. We suggested using the second phase for diagnosing sensitization.
我们研究的目的是确定变应原与过敏患者(花粉症、支气管哮喘和青霉素过敏)以及有过敏反应的动物(阿瑟氏现象、马血清致敏的豚鼠)的血液共同培养时,多形核白细胞诱导的鲁米诺依赖性化学发光强度会受到怎样的影响。所有检测结果都是一致的。在所有情况下,都确定了诱导化学发光变化的三个阶段。在第一阶段,使用最小剂量的特异性和非特异性变应原时,化学发光要么没有变化,要么甚至增加。使用更高剂量的变应原时进入第二阶段——添加特异性变应原时刺激化学发光受到抑制,而使用非特异性变应原的检测中没有变化。我们将此阶段定义为特异性化学发光抑制阶段。随着变应原浓度的进一步增加进入第三阶段。其表现为特异性和非特异性变应原的影响下刺激化学发光均受到抑制。我们将此阶段视为变应原对多形核白细胞毒性影响的表现。我们建议利用第二阶段来诊断致敏情况。